Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Defiance launches four ETFs tracking long and short positions in Bitcoin, Ethereum, and Gold

Defiance launches four ETFs tracking long and short positions in Bitcoin, Ethereum, and Gold

金色财经金色财经2025/05/07 06:04
Show original

According to a report by Jinse Finance, documents submitted by Defiance ETFs, LLC to the U.S. Securities and Exchange Commission (SEC) show that the institution has applied for four new exchange-traded funds, including:

1. Bitcoin vs. Ethereum ETF: Long BTC, short ETH;

2. Ethereum vs. Bitcoin ETF: Short BTC, long ETH;

3. Bitcoin vs. Gold ETF: Long BTC, short gold;

4. Gold vs. Bitcoin ETF: Short BTC, long gold.

It is reported that each fund tracks the leveraged performance of one asset relative to another through derivatives and adopts an active management model, seeking total returns through synthetic exposure to the underlying assets. These funds do not hold spot assets but use a combination of futures contracts, swaps, options, and U.S.-listed ETFs or exchange-traded products (ETPs) to establish leveraged exposure.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

智通财经•2026/10/26 04:20
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks

Goldman Sachs stated that the Japanese yen has become a better tool for hedging against AI shocks, with policy shifts reducing the risk of depreciation. The bank recommends shorting USD/JPY and EUR/JPY.

智通财经•2026/10/26 03:41
Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks